Singapore Medical Device Vigilance Reporting

Regulatory Oversight of the HSA

Regulatory Oversight of the EU Medical Device

The monitoring of medical device safety in Singapore is managed by the Health Sciences Authority, which is commonly referred to as the HSA. Under the Health Products (Medical Devices) Regulations and specific guidance documents such as GN-04-R2, GN-05-R2, and GN-10-R2, manufacturers and their Singapore Registrants are legally required to report adverse events and field safety actions. Failure to comply with these post-market requirements can result in severe financial penalties, criminal charges, or the suspension of device licenses.

Criteria for Reporting Adverse Events

A report must be filed with the HSA if a medical device has contributed to specific negative outcomes for patients or users.

• Events posing a serious threat to public health must be reported.
• Incidents involving the death of a patient, user, or any other individual require notification.
• A serious deterioration in the state of health of a patient, user, or other person must be disclosed.
• Any situation where no death or serious injury occurred, but the event might lead to such outcomes if it were to recur, must also be reported.

Adverse events occurring outside of Singapore generally do not require reporting unless the registration or license conditions specifically mandate it, or if the HSA issues a formal request for that information.

Mandatory Reporting Timelines

The HSA establishes strict windows for the notification of safety issues to ensure rapid regulatory response.

• Field Safety Corrective Actions (FSCAs): The HSA must be notified at least 24 hours before initiating an FSCA.
• Preliminary FSCA Reports: A preliminary report containing thorough information about the action should be submitted within 24 hours.
• Adverse Event Reporting: The submission timeline for initial event reports varies based on the severity of the event, ranging from within hours to several days or weeks.
• Final Reporting: A final recall or incident report must be submitted to the HSA within 21 days.

Administrative Vigilance Reporting Process

The management of safety data follows a structured sequence of actions involving the manufacturer and their local representative.

• The Singapore Registrant and the HSA must be informed as soon as a reportable adverse event has occurred.
• Manufacturers must investigate the root cause of the event and report all findings to the HSA.
• If necessary, the manufacturer must inform the HSA of its Field Safety Corrective Action plan.
• A recall notice detailing the hazards and necessary corrective actions must be distributed to consumers in Singapore.
• A final report summarizing the investigation and outcomes is submitted to the HSA.
• All reports and related correspondence must be integrated into the company's ISO 13485 or quality management system records.

Role of the Singapore Registrant

For international manufacturers, the Singapore Registrant serves as the essential legal liaison with the HSA. This entity is responsible for submitting adverse event reports and recall information on behalf of the manufacturer. The Registrant ensures that all reporting deadlines are met and that the vigilance procedures remain up to date with the latest HSA regulations.

Proregulations' Singapore Vigilance Services

Our team facilitates compliance with HSA post-market requirements through the following specialized service modules.

• Singapore Registrant and HSA representation
  We act as your officially designated Registrant to manage mandatory safety notifications and handle all communications with the HSA.
• Incident reportability and assessment support
  Our experts help determine when an incident meets the criteria for reporting and ensure that initial reports are submitted within the required hourly or daily windows.
• FSCA coordination and notice distribution
  We assist in planning field actions and managing the 24-hour notification requirement, as well as the distribution of recall notices to consumers.
• Regulatory monitoring and guidance alignment
  Our consultants keep your procedures aligned with GN-04-R2, GN-05-R2, and other critical HSA guidance documents.
• Quality system and documentation maintenance
  We ensure that all final reports and vigilance correspondence are properly recorded within your technical files to support future regulatory inspections.

If you are interested in our Singapore medical device vigilance services and wish to secure your market position, please feel free to contact us.